Xtant Medical Holdings, Inc. (XTNT)
Market Cap | 81.42M |
Revenue (ttm) | 101.23M |
Net Income (ttm) | -1.66M |
Shares Out | 130.27M |
EPS (ttm) | -0.01 |
PE Ratio | n/a |
Forward PE | n/a |
Dividend | n/a |
Ex-Dividend Date | n/a |
Volume | 21,997 |
Open | 0.639 |
Previous Close | 0.641 |
Day's Range | 0.625 - 0.670 |
52-Week Range | 0.600 - 1.450 |
Beta | 0.33 |
Analysts | Strong Buy |
Price Target | 2.10 (+236.0%) |
Earnings Date | Jul 30, 2024 |
About XTNT
Xtant Medical Holdings, Inc. provides regenerative medicine products and medical devices for orthopedic and neurological surgeons. It offers OsteoSponge that provides a natural scaffold for cellular in-growth and exposes bone-forming proteins to the healing environment; OsteoSelect DBM Putty to mold into any shape and compressed into bony voids; OsteoSelect PLUS DBM Putty to deliver handling properties and ensure patient safety through validated terminal sterilization; 3Demin, a family of allografts that maximizes osteoconductivity and the oste... [Read more]
Financial Performance
Financial StatementsAnalyst Forecast
According to 2 analysts, the average rating for XTNT stock is "Strong Buy." The 12-month stock price forecast is $2.1, which is an increase of 236.00% from the latest price.
News
![](https://cdn.snapi.dev/images/v1/i/i/press7-2433315.jpg)
Xtant Medical Reports First Quarter 2024 Revenue Growth of 55% and Raises Full Year 2024 Revenue Guidance
Expects Revenue for Full Year 2024 of $116 Million to $120 Million BELGRADE, MT / ACCESSWIRE / May 15, 2024 / Xtant Medical Holdings, Inc. (NYSE American:XTNT), a global medical technology company foc...
![](https://cdn.snapi.dev/images/v1/4/s/conf14-2417961.jpg)
Xtant Medical to Issue First Quarter 2024 Financial Results on May 15, 2024
BELGRADE, MO / ACCESSWIRE / May 8, 2024 / Xtant Medical Holdings, Inc. (NYSE American:XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, to...
![](https://cdn.snapi.dev/images/v1/f/6/press1-2398984.jpg)
Xtant Medical Announces Launch of SimpliGraft™ and SimpliMax™ for Chronic and Acute Wounds
BELGRADE, Mont., April 30, 2024 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal di...
![](https://cdn.snapi.dev/images/v1/0/9/press15-2349423.jpg)
Xtant Medical Announces Record Full Year 2023 Revenue of $91.3 Million
Establishes Full Year 2024 Revenue Guidance of $112 Million - $116 Million BELGRADE, Mont., April 01, 2024 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical tech...
![](https://cdn.snapi.dev/images/v1/s/d/conf9-2336267.jpg)
Xtant Medical to Issue Fourth Quarter and Full Year 2023 Financial Results on April 1, 2024
BELGRADE, Mont., March 21, 2024 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal di...
![](https://cdn.snapi.dev/images/v1/4/c/press1-2314174.jpg)
Xtant Medical Increases Revolving Credit Facility to $17 Million with MidCap Financial
BELGRADE, Mont., March 07, 2024 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal di...
![](https://cdn.snapi.dev/images/v1/w/4/conf3-2294440.jpg)
Xtant Medical to Present at the TD Cowen 44th Annual Healthcare Conference
BELGRADE, Mont., Feb. 26, 2024 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal dis...
![](https://cdn.snapi.dev/images/v1/s/c/conf8-2151249.jpg)
Xtant Medical to Participate in Upcoming Investor Conferences
BELGRADE, Mont., Nov. 09, 2023 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal dis...
![](https://cdn.snapi.dev/images/v1/i/2/press10-2149308.jpg)
Xtant Medical Announces Record Third Quarter Revenue of $25 Million
BELGRADE, Mont., Nov. 09, 2023 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal dis...
![](https://cdn.snapi.dev/images/v1/w/u/press19-2116023.jpg)
Xtant Medical Announces Acquisition of nanOss Production Operations from RTI Surgical
Expands Xtant's Manufacturing Capabilities and Capacity to Drive Growth BELGRADE, Mont., Oct. 23, 2023 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technolo...
![](https://cdn.snapi.dev/images/v1/e/z/press6-2101593.jpg)
Xtant Medical Highlights Growing Product Portfolio at NASS 2023
BELGRADE, Mont., Oct. 12, 2023 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal dis...
![](https://cdn.snapi.dev/images/v1/v/9/press20-2018432.jpg)
Xtant Medical Completes Acquisition of Surgalign's Hardware and Biologics Business
BELGRADE, Mont., Aug. 10, 2023 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal dis...
![](https://cdn.snapi.dev/images/v1/t/z/press20-1998359.jpg)
Xtant Medical Announces Second Quarter Revenue Growth of 32%
Raises 2023 Annual Revenue Guidance to $75 Million - $77 Million BELGRADE, Mont., Aug. 01, 2023 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology comp...
![](https://cdn.snapi.dev/images/v1/b/y/press13-1995350.jpg)
Xtant Medical Wins Auction for Surgalign's Hardware and Biologics Business
Acquisition to Enhance Xtant's Growing Spinal Fusion Devices Portfolio BELGRADE, Mont., July 28, 2023 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technolog...
![](https://cdn.snapi.dev/images/v1/s/8/conf15-1987516.jpg)
Xtant Medical to Issue Second Quarter 2023 Financial Results on August 1, 2023
BELGRADE, Mont., July 25, 2023 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal dis...
![](https://cdn.snapi.dev/images/v1/d/r/press15-1962139.jpg)
Xtant Medical Announces Closing of $15 Million Private Placement
BELGRADE, Mont., July 07, 2023 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal dis...
![](https://cdn.snapi.dev/images/v1/a/0/press12-1956790.jpg)
Xtant Medical Announces $15 Million Private Placement
BELGRADE, Mont., July 03, 2023 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal dis...
![](https://cdn.snapi.dev/images/v1/g/t/press16-1896999.jpg)
Xtant Medical Appoints Lori Mitchell-Keller to Board of Directors
BELGRADE, Mont., May 18, 2023 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal diso...
![](https://cdn.snapi.dev/images/v1/a/z/press12-1870954.jpg)
Xtant Medical Announces First Quarter 2023 Revenue Growth of 38% and Full Year 2023 Revenue Guidance
Initiates Annual Revenue Guidance of $73 Million - $75 Million in Full Year 2023 BELGRADE, Mont., May 04, 2023 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical ...
![](https://cdn.snapi.dev/images/v1/4/a/press15-1785093.jpg)
Xtant Medical Announces Fourth Quarter and Full Year 2022 Financial Results
BELGRADE, Mont., March 07, 2023 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal di...
![](https://cdn.snapi.dev/images/v1/p/v/conf10-1781222.jpg)
Xtant Medical to Issue Fourth Quarter and Full Year 2022 Financial Results on March 7, 2023
BELGRADE, Mont., March 03, 2023 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal di...
![](https://cdn.snapi.dev/images/v1/i/q/conf5-1774088.jpg)
Xtant Medical to Present at the Canaccord Musculoskeletal Conference on March 7, 2023
BELGRADE, Mont., Feb. 28, 2023 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal dis...
![](https://cdn.snapi.dev/images/v1/w/6/press20-1645892.jpg)
Xtant Medical Honors Donor Hero Asante Contreras on the Donate Life Rose Parade® Float
Company Sponsors Donate Life Float at Rose Parade for the Ninth Year
![](https://cdn.snapi.dev/images/v1/m/r/press5-1615802.jpg)
Xtant Medical Announces Third Quarter 2022 Financial Results
BELGRADE, Mont., Nov. 03, 2022 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal dis...
![](https://cdn.snapi.dev/images/v1/v/e/press1-1486899.jpg)
Xtant Medical Announces Second Quarter 2022 Financial Results
BELGRADE, Mont., Aug. 04, 2022 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal dis...